Insmed Incorporated
INSM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30,495,414 | $19,051,353 | $13,797,809 | $12,359,610 |
| - Cash | $334,764 | $1,284,324 | $403,247 | $555,030 |
| + Debt | $745,076 | $739,042 | $1,143,373 | $1,148,877 |
| Enterprise Value | $30,905,726 | $18,506,071 | $14,537,935 | $12,953,457 |
| Revenue | $142,342 | $107,415 | $92,823 | $104,442 |
| % Growth | 32.5% | 15.7% | -11.1% | – |
| Gross Profit | $83,612 | $79,340 | $71,545 | $78,291 |
| % Margin | 58.7% | 73.9% | 77.1% | 75% |
| EBITDA | -$344,323 | -$297,127 | -$232,778 | -$211,739 |
| % Margin | -241.9% | -276.6% | -250.8% | -202.7% |
| Net Income | -$370,021 | -$321,686 | -$256,583 | -$235,548 |
| % Margin | -260% | -299.5% | -276.4% | -225.5% |
| EPS Diluted | -1.75 | -1.7 | -1.42 | -1.32 |
| % Growth | -2.9% | -19.7% | -7.6% | – |
| Operating Cash Flow | -$219,761 | -$205,569 | -$262,088 | -$195,979 |
| Capital Expenditures | -$2,418 | -$3,484 | -$10,070 | -$6,772 |
| Free Cash Flow | -$222,179 | -$209,053 | -$272,158 | -$202,751 |